Hypertrophic cardiomyopathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:


==[[Hypertrophic cardiomyopathy overview|Overview]]==
==[[Hypertrophic cardiomyopathy overview|Overview]]==
==Hystorical Perspective==
==Historical Perspective==
==[[Hypertrophic cardiomyopathy classification|Classification]]==
==[[Hypertrophic cardiomyopathy classification|Classification]]==


Line 22: Line 22:
==[[Hypertrophic cardiomyopathy causes|Causes]]==
==[[Hypertrophic cardiomyopathy causes|Causes]]==


==[[Hypertrophic cardiomyopathy epidemiology and demographics|Epidemiology and Demographcis]]==
==[[Hypertrophic cardiomyopathy epidemiology and demographics|Epidemiology and Demographics]]==
==Risk Factors==
==Risk Factors==
==[[Hypertrophic cardiomyopathy screening|Screening]]==
==[[Hypertrophic cardiomyopathy screening|Screening]]==
Line 30: Line 30:


==Diagnosis==
==Diagnosis==
[[Hypertrophic cardiomyopathy screening|Genetic Testing & Screening]] | [[Hypertrophic cardiomyopathy symptoms|History and Symptoms]] | [[Hypertrophic cardiomyopathy physical examination|Physical examination]] | [[Hypertrophic cardiomyopathy electrocardiogram|Electrocardiogram]] | [[Hypertrophic cardiomyopathy echocardiography|Echocardiography]] | [[Hypertrophic cardiomyopathy MRI|Cardiac MRI]] | [[Hypertrophic cardiomyopathy CT|Cardiac CT]] | [[Hypertrophic cardiomyopathy other imaging findings|Positron Emission Tomography]]
Diagnostic Study of Choice| [[Hypertrophic cardiomyopathy symptoms|History and Symptoms]] | [[Hypertrophic cardiomyopathy physical examination|Physical examination]] | Laboratory findings | [[Hypertrophic cardiomyopathy electrocardiogram|Electrocardiogram]] | X Ray | Echocardiography and Ultrasound | [[Hypertrophic cardiomyopathy CT|CT]] Scan | [[Hypertrophic cardiomyopathy MRI|MRI]] |Other Imaging Findings | Other Diagnostic Studies.


==Treatment==
==Treatment==


*[[Hypertrophic cardiomyopathy treatment strategy|Treatment Strategy]]
*'''Medical therapy''', '''Interventions, Surgery, Primary Prevention, Secondary Prevention, Cost Effectiveness of Therapy, Future or Investigational Therapy'''<br />
 
*'''Medical therapy:''' [[Hypertrophic cardiomyopathy medical treatment#Simple Supportive Measures|Supportive Therapy]] | [[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]]
 
*'''Invasive therapies:''' [[Hypertrophic cardiomyopathy alcohol septal ablation|Alcohol Septal Ablation]] | [[Hypertrophic cardiomyopathy septal myectomy|Septal Myectomy]] | [[Hypertrophic cardiomyopathy ventricular pacing|Ventricular Pacing]] | [[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement|Automatic Implantable Cardiac Defibrillator (AICD) Placement]] | [[Hypertrophic cardiomyopathy invasive therapy guidelines|Septal Reduction Therapy Guidelines]]
 
 
*[[Hypertrophic cardiomyopathy surgery#Cardiac transplantation|Cardiac transplantation]]


====Contraindicated medications====
====Contraindicated medications====

Revision as of 14:36, 20 January 2020

For patient information click here

Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy

CDC on Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy in the news

Blogs on Hypertrophic cardiomyopathy

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent)

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Causes

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice| History and Symptoms | Physical examination | Laboratory findings | Electrocardiogram | X Ray | Echocardiography and Ultrasound | CT Scan | MRI |Other Imaging Findings | Other Diagnostic Studies.

Treatment

  • Medical therapy, Interventions, Surgery, Primary Prevention, Secondary Prevention, Cost Effectiveness of Therapy, Future or Investigational Therapy

Contraindicated medications

Idiopathic hypertrophic subaortic stenosis is considered an absolute contraindication to the use of the following medications:

Special Patient Populations

Asymptomatic Patients | Management During Childhood | Hypotension/Cardiovascular collapse | Pregnancy

2011 ACCF/AHA Guideline Recommendations

Diagnostic testing:

Electrocardiogram | Echocardiography | Stress Testing | Cardiac Magnetic Resonance | Cardiac CT | Positron Emission Tomography

Management:

| Invasive Therapies | Alcohol septal ablation | Septal Myectomy | Pacing | Selection of Patients for ICDs | Selection of ICD-Device type | Selection of Patients for Heart Transplantation

Related Chapters

Resources


Template:WikiDoc Sources